Caught on the wrong foot
24/06/20 -"Solvay’s €1.5bn impairment of the back of the current challenging business situation is the price the current management has to pay for the predecessor’s expensive decisions. The ..."
Pages
60
Language
English
Published on
24/06/20
You may also be interested by these reports :
29/10/26
Wacker’s Q3 2026 sales growth was price-led, reflecting cost pass-through rather than a recovery in demand. The chemicals divisions led earnings, ...
29/10/26
Linde’s Q3 results were broadly in line, with adjusted EPS of US$4.59 exceeding expectations and sales beating consensus by c.2%, potentially driven ...
29/10/26
Air Liquide’s Q326 revenue rose 3% organically to €7.26bn, slightly accelerating from H1’s 2.6%. Electronics and Industrial Merchant drove growth, ...
28/10/26
Symrise delivered another solid quarter, confirming a broader, volume-led recovery, but shares fell c.9%. Following strong peer results and a recent ...